The following is a list of recent US Food and Drug Administration (FDA) updates and activities:

• FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies

• Three Lots of Famotidine Injection USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial by Fresenius Kabi: Recall - Due to Out-of-Specification Endotoxin Results in Certain Reserve Samples

…

Sign Up for Free Trial

---

• Back
• MCN Blog